Principal Securities Inc. Acquires Shares of 404 Everus (NYSE:ECG)

Principal Securities Inc. bought a new stake in Everus (NYSE:ECGFree Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 404 shares of the company’s stock, valued at approximately $27,000.

Several other large investors also recently bought and sold shares of the company. Yousif Capital Management LLC acquired a new position in shares of Everus in the fourth quarter worth $1,326,000. Cascade Investment Advisors Inc. purchased a new position in Everus in the fourth quarter valued at about $1,272,000. Register Financial Advisors LLC acquired a new stake in Everus in the fourth quarter valued at approximately $3,167,000. SG Americas Securities LLC acquired a new position in Everus in the 4th quarter worth $669,000. Finally, Moody Aldrich Partners LLC acquired a new position in shares of Everus in the 4th quarter valued at approximately $4,359,000.

Everus Stock Performance

ECG opened at $41.77 on Friday. The firm has a fifty day simple moving average of $63.72. The company has a quick ratio of 1.50, a current ratio of 1.58 and a debt-to-equity ratio of 0.47. Everus has a 12-month low of $37.84 and a 12-month high of $77.93.

Everus (NYSE:ECGGet Free Report) last announced its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.06). On average, sell-side analysts anticipate that Everus will post 2.49 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ECG. DA Davidson initiated coverage on shares of Everus in a research report on Monday, November 4th. They issued a “neutral” rating and a $55.00 price target on the stock. Wolfe Research initiated coverage on Everus in a research report on Tuesday, December 3rd. They issued a “peer perform” rating for the company. Stifel Nicolaus cut their price objective on Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Finally, Oppenheimer raised their target price on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, January 7th.

Read Our Latest Stock Analysis on ECG

Insider Transactions at Everus

In related news, Director Rocca Michael Della acquired 1,050 shares of the stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average price of $47.56 per share, with a total value of $49,938.00. Following the acquisition, the director now owns 2,027 shares in the company, valued at approximately $96,404.12. The trade was a 107.47 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Maximillian J. Marcy purchased 1,300 shares of the firm’s stock in a transaction on Tuesday, February 25th. The shares were purchased at an average price of $38.99 per share, with a total value of $50,687.00. Following the completion of the acquisition, the chief financial officer now directly owns 5,508 shares of the company’s stock, valued at approximately $214,756.92. This trade represents a 30.89 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 3,750 shares of company stock valued at $153,853 over the last three months.

About Everus

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Read More

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.